No Needles, No Worries: A New Chapter in Diabetes Care

No Needles, No Worries: A New Chapter in Diabetes Care

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Triplet Therapies: A Breakthrough in Leukemia Care

Triplet Therapies: A Breakthrough in Leukemia Care

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

ADA’s 2025 Blueprint for Better Diabetes Care

ADA’s 2025 Blueprint for Better Diabetes Care

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Unveiling the Cardiac Threat: Pioglitazone and Insulin in Diabetes Care

Unveiling the Cardiac Threat: Pioglitazone and Insulin in Diabetes Care

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Standing Blood Pressure and Its Link to Long-Term Cardiovascular Risks

Standing Blood Pressure and Its Link to Long-Term Cardiovascular Risks

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment